Clinical trial Recruiting at 9 sites Observational Ages 18 and up

Observational registry for the Ovation Alto Endograft in treating abdominal aortic aneurysms

Official title: Neck Evolution With Ovation in Spain

Run by DGM Vascular · NCT05823519 · Data updated 2026-11-12

This study is testing the safety and effectiveness of a new device called the Ovation Alto Endograft for treating abdominal aortic aneurysms in patients who need surgery.

More Abdominal Aortic Aneurysm trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment120 (estimated)
SponsorDGM Vascular
Research network
Locations9 sites (Palma de Mallorca, Balearic Islands and 8 other locations)
StatusRecruiting
StartedJune 1, 2022
Main results expectedJanuary 1, 2024
Study endsJanuary 1, 2027
Registry record updatedApril 21, 2023
Trial IDNCT05823519 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older with de novo infrarenal or aorto-iliac AAA who are eligible for endovascular repair with the Ovation Alto Endograft.

Probably not a fit

Patients currently participating in other studies with the same device or endpoint, or those with known allergies to device components, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter, observational registry aims to assess the safety and effectiveness of the Ovation Alto Endograft in patients undergoing endovascular repair for abdominal aortic aneurysms (AAA). A total of 50 to 120 subjects will be enrolled and followed from the procedure to discharge, and then at 1 month, 6 months, 1 year, and annually for up to 3 years. The study will focus on confirming the stability of the neck diameter over time and monitoring any complications associated with the graft. This approach will provide valuable data on the long-term outcomes of this treatment method.

Why it matters

Potential benefit: If successful, this study could enhance the understanding of the Ovation Alto Endograft's long-term safety and effectiveness, potentially improving patient outcomes in AAA treatment.

How similar studies have gone: While this study builds on existing knowledge of endovascular repair techniques, it specifically focuses on the Ovation Alto Endograft, which may provide new insights into its long-term performance.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Male or female at least 18 years old.
2. Subject has signed informed consent for data release.
3. Subjects with de novo infrarenal AAA /aorto-iliac AAA and eligible for endovascular Abdominal Aortic Aneurysm Repair with the Ovation Alto Endograft according to current IFU.

Exclusion Criteria:

1. Currently participating in another study where primary endpoint has not been reached yet.
2. Currently participating in another study with the same devices and/or the same primary endpoint.
3. Known allergy to any of the device components.
4. Pregnant (females of childbearing potential only).

Where it's running

  • Hospital Universitari Son Espases
    Palma de Mallorca, Balearic Islands, Spain
    Recruiting
  • Hospital Universitario De Girona Dr. Josep Trueta
    Girona, Barcelona, Spain
    Recruiting
  • Hospital Universitario De Cruces
    Barakaldo, Bizkaia, Spain
    Recruiting
  • Hospital Universitario De Burgos
    Burgos, Castille and León, Spain
    Recruiting
  • Hospital Universitario de Salamanca
    Salamanca, Castille and León, Spain
    Recruiting
  • Hospital General Universitario De Toledo
    Toledo, Castille-La Mancha, Spain
    Recruiting
Show 3 more locations
  • Hospital Universitario De Cabueñes
    Gijón, Principality of Asturias, Spain
    Recruiting
  • Hospital De La Santa Creu I Sant Pau
    Barcelona, Spain
    Recruiting
  • Hospital Universitario Germans Trias i Pujol
    Barcelona, Spain
    Recruiting

Study contacts

  • Principal investigator: Manuel Alonso Pérez, MD — Hospital Universitario Central de Asturias
  • Study coordinator: Manuel Alonso Pérez, MD
  • Email: manuel.alonsop@sespa.es
  • Phone: 985 10 80 00

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.